MYC addiction in chronic lymphocytic leukemia (Q44879882)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	MYC addiction in chronic lymphocytic leukemia	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23339445

retrieved

7 December 2017

title

MYC addiction in chronic lymphocytic leukemia (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23339445

retrieved

7 December 2017

main subject

lymphocyte

0 references

author name string

Davide Rossi

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23339445

retrieved

7 December 2017

publication date

19 February 2013

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23339445

retrieved

7 December 2017

published in

Leukemia & Lymphoma

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23339445

retrieved

7 December 2017

volume

54

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23339445

retrieved

7 December 2017

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23339445

retrieved

7 December 2017

page(s)

905-906

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23339445

retrieved

7 December 2017

cites work

MYC on the path to cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

The Gray Zone Between Burkitt's Lymphoma and Diffuse Large B-Cell Lymphoma From a Genetics Perspective

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

MAX and MYC: a heritable breakup

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2012.755179

retrieved

21 January 2018

Identifiers

DOI

10.3109/10428194.2012.755179

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23339445

retrieved

7 December 2017

PubMed publication ID

23339445

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23339445

retrieved

7 December 2017

ResearchGate publication ID

235002967

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44879882&oldid=2055081410"